nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—CYP2D6—Parkinson's disease	0.515	0.583	CbGaD
Metoprolol—ABCB1—Parkinson's disease	0.368	0.417	CbGaD
Metoprolol—Alprenolol—HTR1A—Parkinson's disease	0.000967	0.131	CrCbGaD
Metoprolol—Pindolol—HTR1A—Parkinson's disease	0.000831	0.112	CrCbGaD
Metoprolol—Betaxolol—CYP2D6—Parkinson's disease	0.000698	0.0945	CrCbGaD
Metoprolol—Bisoprolol—CYP2D6—Parkinson's disease	0.000674	0.0912	CrCbGaD
Metoprolol—Acebutolol—CYP2D6—Parkinson's disease	0.000639	0.0864	CrCbGaD
Metoprolol—Oxprenolol—CYP2D6—Parkinson's disease	0.000634	0.0858	CrCbGaD
Metoprolol—Alprenolol—CYP2D6—Parkinson's disease	0.00058	0.0784	CrCbGaD
Metoprolol—Pindolol—CYP2D6—Parkinson's disease	0.000499	0.0675	CrCbGaD
Metoprolol—Atenolol—ABCB1—Parkinson's disease	0.000494	0.0668	CrCbGaD
Metoprolol—Acebutolol—ABCB1—Parkinson's disease	0.000456	0.0617	CrCbGaD
Metoprolol—Propranolol—HTR1A—Parkinson's disease	0.000454	0.0614	CrCbGaD
Metoprolol—Propranolol—CYP2D6—Parkinson's disease	0.000272	0.0368	CrCbGaD
Metoprolol—Propranolol—ABCB1—Parkinson's disease	0.000194	0.0263	CrCbGaD
Metoprolol—ADRB1—Signaling Pathways—DGKQ—Parkinson's disease	9.2e-05	0.000836	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—GPR37—Parkinson's disease	9.2e-05	0.000836	CbGpPWpGaD
Metoprolol—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	9.2e-05	0.000835	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—GRM5—Parkinson's disease	9.2e-05	0.000835	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PDYN—Parkinson's disease	9.18e-05	0.000834	CbGpPWpGaD
Metoprolol—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	9.16e-05	0.000831	CbGpPWpGaD
Metoprolol—CYP2C19—Metapathway biotransformation—GSTM1—Parkinson's disease	9.15e-05	0.000831	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—DGKQ—Parkinson's disease	9e-05	0.000817	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—GPR37—Parkinson's disease	9e-05	0.000817	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PDYN—Parkinson's disease	8.98e-05	0.000816	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—DBH—Parkinson's disease	8.91e-05	0.000809	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—GBA—Parkinson's disease	8.91e-05	0.000809	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—FBP1—Parkinson's disease	8.91e-05	0.000809	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	8.86e-05	0.000804	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	8.85e-05	0.000804	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	8.83e-05	0.000802	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	8.72e-05	0.000792	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—GRM5—Parkinson's disease	8.54e-05	0.000775	CbGpPWpGaD
Metoprolol—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	8.53e-05	0.000775	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PPP1R1B—Parkinson's disease	8.42e-05	0.000764	CbGpPWpGaD
Metoprolol—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	8.42e-05	0.000764	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—GRM5—Parkinson's disease	8.35e-05	0.000758	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—EDN1—Parkinson's disease	8.31e-05	0.000755	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PPP1R1B—Parkinson's disease	8.23e-05	0.000748	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—EDN1—Parkinson's disease	8.13e-05	0.000738	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—ADORA2A—Parkinson's disease	7.99e-05	0.000726	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—ADORA2A—Parkinson's disease	7.82e-05	0.00071	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	7.78e-05	0.000707	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	7.74e-05	0.000703	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	7.47e-05	0.000678	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—RIT2—Parkinson's disease	7.36e-05	0.000668	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—HTR2A—Parkinson's disease	7.27e-05	0.00066	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—ADORA2A—Parkinson's disease	7.26e-05	0.000659	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—RIT2—Parkinson's disease	7.2e-05	0.000654	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—HTR2A—Parkinson's disease	7.11e-05	0.000646	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—ADORA2A—Parkinson's disease	7.1e-05	0.000645	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	6.99e-05	0.000634	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—GRK5—Parkinson's disease	6.98e-05	0.000633	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—HTR1A—Parkinson's disease	6.94e-05	0.00063	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—TAC1—Parkinson's disease	6.83e-05	0.00062	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—GRK5—Parkinson's disease	6.82e-05	0.00062	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—HTR1A—Parkinson's disease	6.78e-05	0.000616	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—DRD1—Parkinson's disease	6.7e-05	0.000608	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—TAC1—Parkinson's disease	6.68e-05	0.000607	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—MCCC1—Parkinson's disease	6.58e-05	0.000597	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ND3—Parkinson's disease	6.58e-05	0.000597	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—DRD1—Parkinson's disease	6.55e-05	0.000595	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—DDC—Parkinson's disease	6.54e-05	0.000594	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	6.49e-05	0.00059	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—DRD3—Parkinson's disease	6.49e-05	0.000589	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	6.48e-05	0.000589	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—TNF—Parkinson's disease	6.42e-05	0.000583	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ND3—Parkinson's disease	6.42e-05	0.000583	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—MCCC1—Parkinson's disease	6.42e-05	0.000583	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—DRD3—Parkinson's disease	6.35e-05	0.000576	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—HTR1A—Parkinson's disease	6.3e-05	0.000572	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—GRM4—Parkinson's disease	6.26e-05	0.000568	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	6.23e-05	0.000566	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—TAC1—Parkinson's disease	6.2e-05	0.000563	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—TALDO1—Parkinson's disease	6.18e-05	0.000561	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—OMD—Parkinson's disease	6.18e-05	0.000561	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—GSTA4—Parkinson's disease	6.17e-05	0.00056	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—HTR1A—Parkinson's disease	6.16e-05	0.000559	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—GRM4—Parkinson's disease	6.12e-05	0.000556	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—DRD1—Parkinson's disease	6.08e-05	0.000552	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—TAC1—Parkinson's disease	6.07e-05	0.000551	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—ADRBK1—Parkinson's disease	6.06e-05	0.00055	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ND3—Parkinson's disease	6.05e-05	0.000549	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—MCCC1—Parkinson's disease	6.05e-05	0.000549	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—TALDO1—Parkinson's disease	6.04e-05	0.000548	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—OMD—Parkinson's disease	6.04e-05	0.000548	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	5.97e-05	0.000542	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—DRD1—Parkinson's disease	5.95e-05	0.00054	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PENK—Parkinson's disease	5.93e-05	0.000538	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MAG—Parkinson's disease	5.93e-05	0.000538	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—ADRBK1—Parkinson's disease	5.93e-05	0.000538	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—DRD3—Parkinson's disease	5.89e-05	0.000535	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—HTR7—Parkinson's disease	5.87e-05	0.000533	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—DRD2—Parkinson's disease	5.87e-05	0.000533	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	5.86e-05	0.000532	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MAG—Parkinson's disease	5.8e-05	0.000527	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PENK—Parkinson's disease	5.8e-05	0.000527	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—DRD3—Parkinson's disease	5.76e-05	0.000523	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—HTR7—Parkinson's disease	5.74e-05	0.000521	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—DRD2—Parkinson's disease	5.74e-05	0.000521	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—NDUFB11—Parkinson's disease	5.72e-05	0.00052	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—TALDO1—Parkinson's disease	5.69e-05	0.000516	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—OMD—Parkinson's disease	5.69e-05	0.000516	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GCH1—Parkinson's disease	5.59e-05	0.000508	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PLA2G6—Parkinson's disease	5.56e-05	0.000505	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—MAOB—Parkinson's disease	5.5e-05	0.0005	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—ADRBK1—Parkinson's disease	5.5e-05	0.000499	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GCH1—Parkinson's disease	5.46e-05	0.000496	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PDYN—Parkinson's disease	5.42e-05	0.000493	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	5.39e-05	0.00049	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—ADRBK1—Parkinson's disease	5.38e-05	0.000489	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—DRD2—Parkinson's disease	5.33e-05	0.000484	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—HTR7—Parkinson's disease	5.33e-05	0.000484	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PDYN—Parkinson's disease	5.31e-05	0.000482	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—HTR7—Parkinson's disease	5.21e-05	0.000473	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—DRD2—Parkinson's disease	5.21e-05	0.000473	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GCH1—Parkinson's disease	5.14e-05	0.000467	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—GFAP—Parkinson's disease	5.1e-05	0.000463	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	5.04e-05	0.000458	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—GRM5—Parkinson's disease	5.04e-05	0.000458	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—GFAP—Parkinson's disease	4.99e-05	0.000453	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—DBH—Parkinson's disease	4.98e-05	0.000453	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—FBP1—Parkinson's disease	4.98e-05	0.000453	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GBA—Parkinson's disease	4.98e-05	0.000453	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—GRM5—Parkinson's disease	4.93e-05	0.000448	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GBA—Parkinson's disease	4.87e-05	0.000442	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—FBP1—Parkinson's disease	4.87e-05	0.000442	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—DBH—Parkinson's disease	4.87e-05	0.000442	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—EDN1—Parkinson's disease	4.7e-05	0.000426	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—EDN1—Parkinson's disease	4.59e-05	0.000417	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GBA—Parkinson's disease	4.58e-05	0.000416	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—DBH—Parkinson's disease	4.58e-05	0.000416	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—FBP1—Parkinson's disease	4.58e-05	0.000416	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—FGF20—Parkinson's disease	4.42e-05	0.000401	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	4.36e-05	0.000396	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—FGF20—Parkinson's disease	4.33e-05	0.000393	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ADORA2A—Parkinson's disease	4.29e-05	0.000389	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—EDN1—Parkinson's disease	4.27e-05	0.000387	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.25e-05	0.000386	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ADORA2A—Parkinson's disease	4.19e-05	0.000381	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—EDN1—Parkinson's disease	4.17e-05	0.000379	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—HTR2A—Parkinson's disease	4.11e-05	0.000373	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CYP2D6—Parkinson's disease	4.09e-05	0.000371	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.08e-05	0.000371	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—HTR2A—Parkinson's disease	4.02e-05	0.000365	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CTGF—Parkinson's disease	4.01e-05	0.000364	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	4e-05	0.000364	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—INSR—Parkinson's disease	3.96e-05	0.000359	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—INSR—Parkinson's disease	3.87e-05	0.000351	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CYP2E1—Parkinson's disease	3.74e-05	0.00034	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—FGB—Parkinson's disease	3.74e-05	0.00034	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—HTR2A—Parkinson's disease	3.73e-05	0.000339	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HTR1A—Parkinson's disease	3.72e-05	0.000338	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—NQO1—Parkinson's disease	3.7e-05	0.000336	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TAC1—Parkinson's disease	3.66e-05	0.000333	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—DDC—Parkinson's disease	3.66e-05	0.000332	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—FGB—Parkinson's disease	3.66e-05	0.000332	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—HTR2A—Parkinson's disease	3.65e-05	0.000331	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—TH—Parkinson's disease	3.64e-05	0.000331	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HTR1A—Parkinson's disease	3.64e-05	0.00033	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—DRD1—Parkinson's disease	3.59e-05	0.000326	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TAC1—Parkinson's disease	3.58e-05	0.000325	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—DDC—Parkinson's disease	3.57e-05	0.000324	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.55e-05	0.000322	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—DRD1—Parkinson's disease	3.52e-05	0.000319	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CYCS—Parkinson's disease	3.5e-05	0.000318	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—DRD3—Parkinson's disease	3.48e-05	0.000316	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GSTA4—Parkinson's disease	3.46e-05	0.000314	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.41e-05	0.00031	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—DRD3—Parkinson's disease	3.4e-05	0.000309	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GSTA4—Parkinson's disease	3.37e-05	0.000306	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—DDC—Parkinson's disease	3.37e-05	0.000306	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ADRBK1—Parkinson's disease	3.25e-05	0.000295	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ADRBK1—Parkinson's disease	3.18e-05	0.000289	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GSTA4—Parkinson's disease	3.18e-05	0.000289	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	3.17e-05	0.000288	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—DRD2—Parkinson's disease	3.15e-05	0.000286	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HTR7—Parkinson's disease	3.15e-05	0.000286	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	3.11e-05	0.000282	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—COMT—Parkinson's disease	3.1e-05	0.000281	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—GSTP1—Parkinson's disease	3.08e-05	0.00028	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—MAOB—Parkinson's disease	3.08e-05	0.00028	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—DRD2—Parkinson's disease	3.08e-05	0.00028	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HTR7—Parkinson's disease	3.08e-05	0.00028	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—MAOA—Parkinson's disease	3.08e-05	0.000279	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—HMOX1—Parkinson's disease	3.04e-05	0.000276	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PLA2G6—Parkinson's disease	3.04e-05	0.000276	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—MAOB—Parkinson's disease	3.01e-05	0.000273	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.93e-05	0.000266	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ABCB1—Parkinson's disease	2.92e-05	0.000265	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	2.86e-05	0.00026	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—GSTM1—Parkinson's disease	2.83e-05	0.000257	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—MAOB—Parkinson's disease	2.83e-05	0.000257	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—GPX1—Parkinson's disease	2.71e-05	0.000246	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IGF2—Parkinson's disease	2.64e-05	0.000239	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IGF2—Parkinson's disease	2.58e-05	0.000234	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IGF1R—Parkinson's disease	2.55e-05	0.000232	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—EDN1—Parkinson's disease	2.52e-05	0.000229	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—MTHFR—Parkinson's disease	2.51e-05	0.000227	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IGF1R—Parkinson's disease	2.49e-05	0.000226	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—EDN1—Parkinson's disease	2.46e-05	0.000224	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—APOE—Parkinson's disease	2.33e-05	0.000212	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NGF—Parkinson's disease	2.32e-05	0.00021	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	2.29e-05	0.000208	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NGF—Parkinson's disease	2.27e-05	0.000206	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CTGF—Parkinson's disease	2.25e-05	0.000204	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP2D6—Parkinson's disease	2.23e-05	0.000203	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HTR2A—Parkinson's disease	2.2e-05	0.0002	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CTGF—Parkinson's disease	2.19e-05	0.000199	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HTR2A—Parkinson's disease	2.16e-05	0.000196	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	2.09e-05	0.00019	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—NQO1—Parkinson's disease	2.07e-05	0.000188	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.07e-05	0.000188	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—APOE—Parkinson's disease	2.05e-05	0.000186	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP2E1—Parkinson's disease	2.04e-05	0.000186	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—TH—Parkinson's disease	2.04e-05	0.000185	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—NQO1—Parkinson's disease	2.02e-05	0.000183	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—APOE—Parkinson's disease	2e-05	0.000182	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—INS—Parkinson's disease	1.99e-05	0.000181	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—TH—Parkinson's disease	1.99e-05	0.000181	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYCS—Parkinson's disease	1.96e-05	0.000178	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.93e-05	0.000175	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYCS—Parkinson's disease	1.91e-05	0.000174	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.9e-05	0.000173	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—TH—Parkinson's disease	1.88e-05	0.00017	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.8e-05	0.000164	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—INS—Parkinson's disease	1.75e-05	0.000159	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—COMT—Parkinson's disease	1.73e-05	0.000157	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GSTP1—Parkinson's disease	1.73e-05	0.000157	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—MAOA—Parkinson's disease	1.72e-05	0.000156	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—INS—Parkinson's disease	1.71e-05	0.000155	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—HMOX1—Parkinson's disease	1.7e-05	0.000155	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—COMT—Parkinson's disease	1.69e-05	0.000154	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GSTP1—Parkinson's disease	1.69e-05	0.000153	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—MAOA—Parkinson's disease	1.68e-05	0.000153	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—HMOX1—Parkinson's disease	1.66e-05	0.000151	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ABCB1—Parkinson's disease	1.63e-05	0.000148	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—COMT—Parkinson's disease	1.6e-05	0.000145	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.59e-05	0.000144	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GSTM1—Parkinson's disease	1.59e-05	0.000144	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.58e-05	0.000144	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.57e-05	0.000142	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GSTM1—Parkinson's disease	1.55e-05	0.000141	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GPX1—Parkinson's disease	1.52e-05	0.000138	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.5e-05	0.000136	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GPX1—Parkinson's disease	1.48e-05	0.000135	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.46e-05	0.000132	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—MTHFR—Parkinson's disease	1.4e-05	0.000127	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.4e-05	0.000127	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—MTHFR—Parkinson's disease	1.37e-05	0.000124	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—APOE—Parkinson's disease	1.31e-05	0.000119	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CASP3—Parkinson's disease	1.3e-05	0.000118	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—IL6—Parkinson's disease	1.29e-05	0.000118	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.29e-05	0.000117	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CASP3—Parkinson's disease	1.28e-05	0.000116	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—APOE—Parkinson's disease	1.27e-05	0.000116	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—IL6—Parkinson's disease	1.27e-05	0.000115	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—APOE—Parkinson's disease	1.2e-05	0.000109	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MAPK8—Parkinson's disease	1.2e-05	0.000109	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MAPK8—Parkinson's disease	1.17e-05	0.000106	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—INS—Parkinson's disease	1.12e-05	0.000101	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—INS—Parkinson's disease	1.09e-05	9.88e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—INS—Parkinson's disease	1.03e-05	9.31e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IL6—Parkinson's disease	7.65e-06	6.95e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IL6—Parkinson's disease	7.48e-06	6.79e-05	CbGpPWpGaD
